(Reuters) – Moderna Inc’s (MRNA.O) Stocks increased by about 11% on Wednesday after a small-scale study showed that its experimental COVID-19 vaccine produced high levels of virus-killing antibodies, raising hopes that the vaccine could be effective in later stages of testing. FILE PHOTO: A sign marks the headquarters of Moderna …
Read More »
Stocks ended Wednesday on the upside with the news that a candidate Coronavirus vaccine from Moderna (MRNA) – Get report produced the desired immune response and that group Goldman Sachs (GS) – Get report posted stronger earnings than expected. Optimism was somewhat affected by reports that China promised to retaliate …
Read More »
First COVID-19 The vaccine tested in the U.S. boosted people’s immune systems just as scientists expected, researchers reported Tuesday. The shots are set to begin the key final test. “No matter how this is cut, this is good news” Dr. Anthony Fauci, the U.S. government’s leading infectious disease expert, told …
Read More »
Moderna’s shares rose as much as 18% on Wednesday after the company announced that an early test of the coronavirus vaccine produced antibodies in all participants. A dose range induced immune responses in all 45 patients in the phase 1 trial and was “generally safe and well tolerated,” Moderna said …
Read More »
Text size It is good to be the Dow. The stock market continues to rise on Wednesday, but some indices are rising more than others. S&P 500 futures are up 1.4%, while Dow Jones Industrial Average futures are up 566 points, or 2.1%, and Nasdaq Composite is up just 0.5%. …
Read More »